Clinical trials
Hereditary Sensory and Autonomic Neuropathies trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 6 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aalborg University | 2 |
| General Hospital of Ningxia Medical University | 2 |
| Alanya Alaaddin Keykubat University | 1 |
| Beni-Suef University | 1 |
| Cairo University | 1 |
| Children's Hospital Zagreb | 1 |
| Ege University | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Institut de Cancérologie de Lorraine | 1 |
| Medical University of South Carolina | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hereditary Sensory and Autonomic Neuropathies | 20 |
| Diabetes Mellitus, Type 2 | 2 |
| Diabetic Neuropathies | 2 |
| Postoperative Cognitive Complications | 2 |
| Alzheimer Disease | 1 |
| Bone Diseases, Metabolic | 1 |
| Breast Neoplasms | 1 |
| Convalescence | 1 |
| Dysautonomia, Familial | 1 |
| Embolism and Thrombosis | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.